Pharma Journalist -

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved the self-administration of Fasenra (benralizumab) in a pre-filled, single-use auto-injector (the…
Read More...

Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, announced it entered…
Read More...

Prometheus Biosciences, Inc., a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and…
Read More...

Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NMPA) in…
Read More...

Elicio Therapeutics, a next generation immuno-oncology company, announced that it has closed its $33 million Series B financing. Proceeds from the financing will be used to advance…
Read More...

Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and…
Read More...

Cellular Biomedicine Group, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced it…
Read More...

GlaxoSmithKline plc (GSK) and Innoviva, Inc. (INVA) announced the filing of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) seeking an additional…
Read More...

Xylyx Bio announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Through the development of…
Read More...

Thermo Fisher Scientific announced the expansion of its API manufacturing capabilities following the completion of its previously announced acquisition of an active pharmaceutical…
Read More...